Drug shortage
Quinapril/Hydrochlorothiazide Tablet · Aurobindo Pharma USA
FDA drug shortage · Current · updated Mar 17, 2025
Key facts
| Generic name | Quinapril/Hydrochlorothiazide Tablet |
|---|---|
| Proprietary name | Quinapril Hydrochloride And Hydrochlorothiazide |
| Company | Aurobindo Pharma USA |
| Presentation | Quinapril Hydrochloride And Hydrochlorothiazide, Tablet, 12.5 mg; 20 mg (NDC 65862-162-90) |
| Dosage form | Tablet |
| Strength | 12.5 mg 20 mg |
| Status | Current |
| Reason for shortage | Discontinuation of the manufacture of the drug |
| Therapeutic category | Cardiovascular |
| Package NDCs | 65862-162-90 |
| First posted | Jan 19, 2023 |
| Last updated | Mar 17, 2025 |
At a glance
- 1–9 Package NDCs affected
- 10–99 FDA shortage records for this drug
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug shortages
The FDA Drug Shortages Database lists current and resolved shortages of drugs, with presentations, affected NDCs and reasons reported by manufacturers.
Source: U.S. Food and Drug Administration (FDA), Drug Shortages Database · Source date: